The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice
Open accessAbstract
Mice with targeted deletion of the gene for interleukin-10 (IL-10) spontaneously develop enterocolitis when maintained in conventional conditions but develop only colitis when kept in specific-pathogen-free (SPF) environments. This study tested the hypothesis that enteric bacteria are necessary for the development of spontaneous colitis and immune system activation in IL-10-deficient mice. IL-10-deficient mice were maintained in either SPF conditions or germfree conditions or were populated with bacteria known to cause colitis in other rodent models. IL-10-deficient mice kept in SPF conditions developed colitis in all segments of the colon (cecum and proximal and distal colon). These mice exhibited immune system activation as evidenced by increased expression of CD44 on CD4 + T cells; increased mesenteric lymph node cell numbers; and increased production of immunoglobulin A (IgA), IgG1, and IL-12 p40 from colon fragment cultures. Mice populated with bacterial strains, including Bacteroides vulgatus , known to induce colitis in other rodent models had minimal colitis. Germfree IL-10-deficient mice had no evidence of colitis or immune system activation. We conclude therefore that resident enteric bacteria are necessary for the development of spontaneous colitis and immune system activation in IL-10-deficient mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D. M., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,248
Self-citationIL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A. A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,439
Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P. J. L., Lanzavecchia, A., & Alber, G. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.747 · Cited by 1,982
Moore, K. W., O’Garra, A., Malefyt, R. D. W., Vieira, P., & Mosmann, T. R. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001121 · Cited by 1,883
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,866
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. D. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Identification of a monoclonal antibody specific for a murine T3 polypeptide.
Léo, O., Foo, M., Sachs, D. H., Samelson, L. E., & Bluestone, J. A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1374 · Cited by 1,596
D’Andrea, A., Aste-Amézaga, M., Valiante, N. M., Ma, X., Kubin, M. Z., & Trinchieri, G. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,367
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath, M., Fuss, I. J., Kelsall, B. L., Stuber, E. R., & Strober, W. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1281 · Cited by 1,334
Research works printed but not linked: 1
- MacDonald T. T. Carter P. B. Contact sensitivity in germfree mice.J. Reticuloendothel. Soc.241978287293
Cited by
Sorted by citations
Items 501–600 of 1,000
Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy
Serban, D. E. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615606898 · Cited by 79
The development of colitis in Il10 mice is dependent on IL-22
Gunasekera, D. C., Ma, J., Vacharathit, V., Shah, P. M., Ramakrishnan, A., Uprety, P., Shen, Z., Sheh, A., Brayton, C. F., Whary, M. T., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-019-0252-3 · Cited by 77
Minshawi, F., Lanvermann, S., McKenzie, E. A., Jeffery, R., Couper, K. N., Papoutsopoulou, S., Roers, A., & Müller, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01794 · Cited by 76
Microbiota therapeutics for inflammatory bowel disease: the way forward
Bethlehem, L., Estevinho, M. M., Grinspan, A. M., Magro, F., Faith, J. J., & Colombel, J. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00441-7 · Cited by 85
The Role of Glycogen Synthase Kinase 3 in Regulating IFN-β–Mediated IL-10 Production
Wang, H., Brown, J. R., Garcia, C. A., Tang, Y., Benakanakere, M. R., Greenway, T., Alard, P., Kinane, D. F., & Martin, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001473 · Cited by 80
The interplay between microbes and the immune response in inflammatory bowel disease
Goethel, A., Croitoru, K., & Philpott, D. J. (2018) · The Journal of Physiology · doi:10.1113/jp275396 · Cited by 78
Zhao, Y., Guo, Q., Zhu, Q., Tan, R. X., Bai, D., Bu, X., Lin, B., Zhao, K., Pan, C., Chen, H., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0177-x · Cited by 74
Cutting Edge: IFN-γ Is a Negative Regulator of IL-23 in Murine Macrophages and Experimental Colitis
Sheikh, S. Z., Matsuoka, K., Kobayashi, T., Li, F., Rubinas, T. C., & Plevy, S. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903600 · Cited by 75
Chen, H., Yang, J., Zhang, M., Zhou, Y.-K., Shen, T., Chu, Z.-X., Zhang, M., Hang, X., Jiang, Y., & Qin, H. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00196.2010 · Cited by 75
Sartor, R. B. (2011) · Mucosal Immunology · doi:10.1038/mi.2010.87 · Cited by 75
Self-citationProbiotics in inflammatory bowel disease: a critical review
Tamboli, C., Caucheteux, C., Cortot, A., Colombel, J., & Desreumaux, P. (2003) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/s1521-6918(03)00076-3 · Cited by 75
Hudson, L. E., Anderson, S. E., Corbett, A. H., & Lamb, T. J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00049-16 · Cited by 76
Horowitz, J. E., Warner, N. E., Staples, J. C., Crowley, E., Gosalia, N., Murchie, R., Hout, C. V. V., Fiedler, K. B., Welch, G., King, A. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84938-8 · Cited by 80
Engineering cytokines for cancer immunotherapy: a systematic review
Fu, Y., Tang, R., & Zhao, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1218082 · Cited by 78
Nonpathogenic Escherichia coli Strain Nissle1917 Prevents Murine Acute and Chronic Colitis
Kamada, N., Inoue, N., Hisamatsu, T., Okamoto, S., Matsuoka, K., Sato, T., Chinen, H., Hong, K. S., Yamada, T., Suzuki, Y., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000158158.55955.de · Cited by 74
Carvalho, F. A., Nalbantoglu, I., Ortega-Fernandez, S., Aitken, J. D., Su, Y., Koren, O., Walters, W. A., Knight, R. D., Ley, R. E., Vijay–Kumar, M., et al. (2011) · Gut · doi:10.1136/gut.2011.240556 · Cited by 75
Rodriguez‐Palacios, A., Kodani, T., Kaydo, L., Pietropaoli, D., Corridoni, D., Howell, S. J., Katz, J., Xin, W., Pizarro, T. T., & Cominelli, F. (2015) · Nature Communications · doi:10.1038/ncomms8577 · Cited by 73
Hyun, J., Romero, L., Riveron, R., Flores, C., Kanagavelu, S. K., Chung, K. D., Alonso, A., Sotolongo, J. P., Ruiz, J. R., Manukyan, A., et al. (2014) · Journal of Innate Immunity · doi:10.1159/000365417 · Cited by 77
Lammers, K. M., Vergopoulos, A., Babel, N., Gionchetti, P., Rizzello, F., Morselli, C., Caramelli, E., Fiorentino, M., D’Errico, A., Volk, H., et al. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mpa.0000160302.40931.7b · Cited by 73
Obata, Y., Takahashi, D., Ebisawa, M., Kakiguchi, K., Yonemura, S., Jinnohara, T., Kanaya, T., Fujimura, Y., Ohmae, M., Hase, K., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101128 · Cited by 71
Haileselassie, Y., Navis, M., Vu, N., Qazi, K. R., Réthi, B., & Sverremark‐Ekström, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00096 · Cited by 72
Gut microbiota in autoimmunity: potential for clinical applications
Kim, D.-H., Yoo, S., & Kim, W. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0796-7 · Cited by 72
Essential immunologic orchestrators of intestinal homeostasis
Zhou, L., & Sonnenberg, G. F. (2018) · Science Immunology · doi:10.1126/sciimmunol.aao1605 · Cited by 74
Immune Networks in Animal Models of Inflammatory Bowel Disease
Mizoguchi, A., Mizoguchi, E., & Bhan, A. K. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200307000-00005 · Cited by 72
Wang, Y., Meng, X.-C., Dong, Y., Zhao, X., Qian, J., Wang, H., & Li, J. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000308 · Cited by 74
Loricrin: Past, Present, and Future
Ishitsuka, Y., & Roop, D. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072271 · Cited by 76
The effects of the microbiota on the host immune system
Karczewski, J., Poniedziałek, B., Adamski, Z., & Rzymski, P. (2014) · Autoimmunity · doi:10.3109/08916934.2014.938322 · Cited by 73
Hegazi, R. A. F., Saad, R. S., Mady, H. H., Matarese, L. E., O’Keefe, S. J., & Kandil, H. M. (2006) · Nutrition · doi:10.1016/j.nut.2005.06.006 · Cited by 71
The role of barrier function, autophagy, and cytokines in maintaining intestinal homeostasis
Elshaer, D., & Begun, J. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.018 · Cited by 72
Time to include the gut microbiota in the hygienic standardisation of laboratory rodents
Bleich, A., & Hansen, A. K. (2012) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2011.12.006 · Cited by 82
Effect of barrier microbes on organ-based inflammation
Garn, H., Neves, J. F., Blumberg, R. S., & Renz, H. E. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.031 · Cited by 70
Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases
Dubinsky, M. C., & Braun, J. G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.006 · Cited by 71
Lin, H., Barnett, M. P. G., Roy, N. C., Joyce, N. I., Zhu, S., Armstrong, K., Helsby, N. A., Ferguson, L. R., & Rowan, D. D. (2010) · Journal of Proteome Research · doi:10.1021/pr901130s · Cited by 70
Sheil, B., MacSharry, J. A., O'Callaghan, L., O'Riordan, A., Waters, A., Morgan, J. G., Collins, J. K., O’Mahony, L., & Shanahan, F. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03051.x · Cited by 70
Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II)
Chandran, P., Satthaporn, S., Robins, A., & Eremin, O. (2003) · The Surgeon · doi:10.1016/s1479-666x(03)80091-4 · Cited by 70
Oft, M. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101325 · Cited by 71
Pereira, G. V., Boudaud, M., Wolter, M., Alexander, C., Sciscio, A. D., Grant, E. T., Trindade, B. C., Pudlo, N. A., Singh, S., Campbell, A., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.03.001 · Cited by 78
Urinary Metabolic Profiles of Inflammatory Bowel Disease in Interleukin-10 Gene-Deficient Mice
Murdoch, T. B., Fu, H., MacFarlane, S. M., Sydora, B. C., Fedorak, R. N., & Slupsky, C. M. (2008) · Analytical Chemistry · doi:10.1021/ac8005236 · Cited by 69
Munyaka, P. M., Sepehri, S., Ghia, J., & Khafipour, E. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00462 · Cited by 72
The Gut Microflora and Its Variety of Roles in Health and Disease
Frick, J.-S., & Autenrieth, I. B. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_217 · Cited by 71
Low prevalence of Blastocystis sp. in active ulcerative colitis patients
Rossen, N., Bart, A., Verhaar, N., van Nood, E., Kootte, R. S., de Groot, P. F., D’Haens, G., Ponsioen, C. Y., & van Gool, T. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2312-2 · Cited by 73
Dobranowski, P., Tang, C., Sauvé, J. P., Menzies, S. C., & Sly, L. M. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1560767 · Cited by 68
Alleviation of Intestinal Inflammation by Oral Supplementation With 2-Fucosyllactose in Mice
Grabinger, T., Garzon, J. F. G., Hausmann, M., Geirnaert, A., Lacroix, C., & Hennet, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01385 · Cited by 72
Nitric oxide released by lactobacillus farciminis improvesTNBS‐induced colitis in rats
Lamine, F., Fioramonti, J., Bueno, L. P., Nepveu, F., Cauquil, E., Lobysheva, I. I., Eutamène, H., & Théodorou, V. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310007152 · Cited by 68
T‐cell activation in the intestinal mucosa
Montufar‐Solis, D., Garza, T., & Klein, J. R. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00471.x · Cited by 67
Barnett, M. P. G., McNabb, W. C., Cookson, A. L., Zhu, S., Davy, M. W., Knoch, B., Nones, K., Hodgkinson, A. J., & Roy, N. C. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-39 · Cited by 66
Hamano, S., Asgharpour, A., Stroup, S. E., Wynn, T. A., Leiter, E. H., & Houpt, E. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1208 · Cited by 67
Helminthic Therapy: Using Worms to Treat Immune-Mediated Disease
Elliott, D. E., & Weinstock, J. V. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1601-3_12 · Cited by 66
Leccese, G., Bibi, A., Mazza, S., Facciotti, F., Caprioli, F., Landini, P., & Paroni, M. (2020) · Cells · doi:10.3390/cells9081824 · Cited by 66
Substance P Regulates Th1-Type Colitis in IL-10 Knockout Mice
Weinstock, J. V., Blum, A. M., Metwali, A., Elliott, D. E., Bunnett, N. W., & Arsenescu, R. I. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3762 · Cited by 66
Carcinoembryonic antigen (CEACAM) family members and Inflammatory Bowel Disease
Kelleher, M., Singh, R., O’Driscoll, C. M., & Melgar, S. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.05.008 · Cited by 65
Andoh, A., Tsujikawa, T., Sasaki, M., Mitsuyama, K., Suzuki, Y., Matsui, T., Matsumoto, T., Benno, Y., & Fujiyama, Y. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03860.x · Cited by 64
Stehr, M., Greweling‐Pils, M. C., Tischer, S., Singh, M., Blöcker, H., Monner, D. A., & Müller, W. (2009) · Laboratory Animals · doi:10.1258/la.2009.0080075 · Cited by 65
Intestinal microbiome as a novel therapeutic target for local and systemic inflammation
Uchiyama, K., Naito, Y., & Takagi, T. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.006 · Cited by 65
Impact of dietary manganese on experimental colitis in mice
Choi, E., Aring, L., Das, N. K., Solanki, S. A., Inohara, N., Iwase, S., Samuelson, L. C., Shah, Y. M., & Seo, Y. A. (2019) · The FASEB Journal · doi:10.1096/fj.201902396r · Cited by 65
Verdugo‐Meza, A., Ye, J., Dadlani, H., Ghosh, S., & Gibson, D. L. (2020) · Nutrients · doi:10.3390/nu12051434 · Cited by 69
Harris, K. G., & Chang, E. B. (2018) · Clinical Science · doi:10.1042/cs20171110 · Cited by 66
Nagamine, C. M., Rogers, A. B., Fox, J. G., & Schauer, D. B. (2007) · International Journal of Cancer · doi:10.1002/ijc.23175 · Cited by 64
Nontargeted Urinary Metabolite Profiling of a Mouse Model of Crohn’s Disease
Lin, H., Edmunds, S. J., Helsby, N. A., Ferguson, L. R., & Rowan, D. D. (2009) · Journal of Proteome Research · doi:10.1021/pr800999t · Cited by 63
Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer
Coleman, O. I., & Haller, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01927 · Cited by 66
Genetics of inflammatory bowel disease: scientific and clinical implications
Satsangi, J., Morecroft, J. A., Shah, N., & Nimmo, E. R. (2003) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0349 · Cited by 64
Mähler, M., Most, C., Schmidtke, S., Sundberg, J. P., Li, R., Hedrich, H. J., & Churchill, G. A. (2002) · Genomics · doi:10.1006/geno.2002.6840 · Cited by 64
Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease
Jergens, A. E., Parvinroo, S., Kopper, J., & Wannemuehler, M. J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.669913 · Cited by 63
Tao, J., Duan, J., Jiang, S., Guo, J., Qian, Y., & Qian, D. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.07.002 · Cited by 63
Interleukin-10-based therapy for inflammatory bowel disease
Braat, H., Peppelenbosch, M. P., & Hommes, D. W. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.5.725 · Cited by 63
Use of lactobacillus-GG in paediatric Crohn's disease
Guandalini, S. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80167-0 · Cited by 63
Colitis-induced Bone Loss is Gender Dependent and Associated with Increased Inflammation
Irwin, R., Lee, T., Young, V. B., Parameswaran, N., & McCabe, L. R. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318289e17b · Cited by 62
Boirivant, M., & Cossu, A. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01811.x · Cited by 65
Dietary Patterns and Gut Microbiota: The Crucial Actors in Inflammatory Bowel Disease
He, P., Yu, L., Tian, F., Zhang, H., Chen, W., & Zhai, Q. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac029 · Cited by 65
Protective effects of cathelicidin‐encoding Lactococcus lactis in murine ulcerative colitis
Wong, C. C. M., Zhang, L., Li, Z. J., Wu, W. K. K., Ren, S. X., Chen, Y., Ng, T. B., & Cho, C. H. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07158.x · Cited by 61
Sydora, B. C., Tavernini, M. M., Wessler, A., Jewell, L. D., & Fedorak, R. N. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200303000-00002 · Cited by 61
Whelan, K. (2013) · Proceedings of The Nutrition Society · doi:10.1017/s0029665113001262 · Cited by 61
Roy, N. C., Barnett, M. P. G., Knoch, B., Dommels, Y. E. M., & McNabb, W. C. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.04.003 · Cited by 61
Shen, Z., Feng, Y., Rogers, A. B., Rickman, B. H., Whary, M. T., Xu, S., Clapp, K. M., Boutin, S. R., & Fox, J. G. (2009) · Infection and Immunity · doi:10.1128/iai.00166-09 · Cited by 61
Quraishi, M. N., Shaheen, W., Oo, Y. H., & Iqbal, T. H. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13397 · Cited by 65
Sharma, U., Olson, R., Erhart, F. N., Zhang, L., Meng, J., Segura, B. J., Banerjee, S., Sharma, M., Saluja, A. K., Ramakrishnan, S., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz188 · Cited by 63
TNFα production to TLR2 ligands in active IBD patients
Cantó, E., Ricart, E., Monfort, D., González-Juan, D., Balanzó, J., Rodríguez-Sánchez, J. L., & Vidal, S. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.12.005 · Cited by 61
Analysis of the large bowel microbiota of colitic mice using PCR/DGGE
Bibiloni, R., Simon, M. A., Albright, C. A., Sartor, B. R., & Tannock, G. W. (2005) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2005.01720.x · Cited by 61
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?
Bringiotti, R. (2014) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v5.i4.550 · Cited by 65
Huang, T., Chu, H.-C., Lin, Y., Lin, C.-K., Hsieh, T., Chang, W., Chao, Y., & Liao, C. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.02.026 · Cited by 60
T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome
Larmonier, C. B., Shehab, K. W., Ghishan, F. K., & Kiela, P. R. (2015) · BioMed Research International · doi:10.1155/2015/504638 · Cited by 61
Using metabolomic analysis to understand inflammatory bowel diseases
Lin, H., Helsby, N. A., Rowan, D. D., & Ferguson, L. R. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21426 · Cited by 61
Karrasch, T., Kim, J., Jang, B. I., & Jobin, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000596 · Cited by 60
Frick, J.-S., Fink, K., Kahl, F., Niemiec, M. J., Quitadamo, M., Schenk, K., & Autenrieth, I. B. (2007) · Infection and Immunity · doi:10.1128/iai.00119-07 · Cited by 60
The Hypoxia–Adenosine Link during Intestinal Inflammation
Bowser, J. L., Phan, L. H., & Eltzschig, H. K. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701414 · Cited by 62
Esworthy, R. S., Binder, S., Doroshow, J. H., & Chu, F.-F. (2003) · Biological Chemistry · doi:10.1515/bc.2003.067 · Cited by 60
Intestinal flora and mucosal immune responses
Heller, F., & Duchmann, R. (2003) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00246 · Cited by 60
The effect of proteasome inhibitor MG132 on experimental inflammatory bowel disease
Inoue, S., Nakase, H., Matsuura, M., Mikami, S., Ueno, S., Uza, N., & Chiba, T. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03872.x · Cited by 60
Tomczak, M. F., Erdman, S. E., Poutahidis, T., Rogers, A. B., Holcombe, H. R., Plank, B., Fox, J. G., & Horwitz, B. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1484 · Cited by 60
Human Defensins in Crohn’s Disease
Wehkamp, J., Fellermann, K., & Stange, E. F. (2005) · KARGER eBooks · doi:10.1159/000086672 · Cited by 60
Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse
Manjili, S. H., Isbell, M., Ghochaghi, N., Perkinson, T., & Manjili, M. H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.023 · Cited by 61
Okayasu, I. (2012) · Pathology International · doi:10.1111/j.1440-1827.2012.02807.x · Cited by 59
Wang, M., Molin, G., Ahrné, S., Adawi, D., & Jeppsson, B. W. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9461-1 · Cited by 59
Bacteria Regulate Intestinal Epithelial Cell Differentiation Factors Both In Vitro and In Vivo
Becker, S., Oelschlaeger, T. A., Wullaert, A., Pasparakis, M., Wehkamp, J., Stange, E. F., & Gersemann, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055620 · Cited by 59
Kajino‐Sakamoto, R., Omori, E., Nighot, P. K., Blikslager, A. T., Matsumoto, K., & Ninomiya‐Tsuji, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903587 · Cited by 58
de Buhr, M. F., Mähler, M., Geffers, R., Hansen, W., Westendorf, A. M., Lauber, J., Buer, J., Schlegelberger, B., Hedrich, H. J., & Bleich, A. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00022.2005 · Cited by 58
A single early-in-life antibiotic course increases susceptibility to DSS-induced colitis
Özkul, C., Ruiz, V. E., Battaglia, T., Xu, J., Baudron, C. R., Cadwell, K., Perez-Perez, G. I., & Blaser, M. J. (2020) · Genome Medicine · doi:10.1186/s13073-020-00764-z · Cited by 57
Role of Emerging Campylobacter Species in Inflammatory Bowel Diseases
Kaakoush, N. O., Mitchell, H. M., & Man, S. M. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000074 · Cited by 60
Gene expression patterns in experimental colitis in IL-10-deficient mice
Hansen, J. J., Holt, L. C., & Sartor, R. B. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20850 · Cited by 57
Self-citationProbiotics: time for a dose of realism.
Tannock, G. W. (2003) · PubMed · Cited by 57
Metadata
- Authors
- Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B.
- Affiliations
- <!--label omitted: 1-->Department of Companion Animal and Special Species1 and
- North Carolina State University (US)
- University of North Carolina at Chapel Hill (US)
- <!--label omitted: 4-->Departments of Surgery and Microbiology, University of Wisconsin, Madison, Wisconsin,4 and
- <!--label omitted: 5-->Department of Immunology, DNAX Corporation, Palo Alto, California5
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 1998-11
- Volume
- 66
- Issue
- 11
- Pages
- 5224-5231
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC108652
- OpenAlex
- W2165528446
- Cited by
- 1,483
- References
- 56
- Citations by year
- 2026: 24 · 2025: 26 · 2024: 37 · 2023: 34 · 2022: 48 · 2021: 48 · 2020: 42 · 2019: 71 · 2018: 61 · 2017: 55 · 2016: 61 · 2015: 73 · 2014: 89 · 2013: 77 · 2012: 70
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Infection and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- interleukin-10 deficiency, spontaneous colitis, enteric bacteria, germ-free mice, specific pathogen-free mice, immune activation, Bacteroides vulgatus, CD4+ T cells, CD44, mesenteric lymph nodes, immunoglobulin A, IL-12p40
- MeSH terms
- Animals, Colitis, Disease Models, Animal, Enterobacteriaceae, Immune System, Inflammation, Intestine, Large, Lymphocyte Activation, Mice, Inbred C57BL, Specific Pathogen-Free Organisms, Interleukin-10, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review